![](/etc.clientlibs/bdb-aem/clientlibs/clientlib-base/resources/icons/blankimage.png)
Old Browser
BD Pharm Lyse™ Lysing Buffer
(RUO)![Lysing Buffer](/content/dam/bdb/products/global/reagents/cell-preparation-separation-reagents/blood-lysis/staining-and-cell-preparation/555899_base/35221E_555899_Figure.png)
Scatter profile of human whole blood treated with BD Pharm Lyse™.
![Lysing Buffer](/content/dam/bdb/products/global/reagents/cell-preparation-separation-reagents/blood-lysis/staining-and-cell-preparation/555899_base/35221E_555899_Figure.png)
BD Pharm Lyse™ Lysing Buffer
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
BD Pharm Lyse™ lysing solution is a buffered, concentrated (10X) ammonium chloride-based lysing reagent. When diluted to a 1X concentration and used as recommended, BD Pharm Lyse™ lyses red blood cells following monoclonal antibody staining. The lysing solution results in good light scatter separation of lymphocytes and red blood cell debris when analyzed by flow cytometry. BD Pharm Lyse™ does not contain a fixative agent, so leukocytes remain viable after red blood cell lysis.
Preparation And Storage
1X diluted solutions may be stored at 4° C for up to 30 days.
Recommended Assay Procedures
Preparation of 1X lysing solution: Dilute the 10X concentrate 1:10 with distilled water. The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Lysing procedure:
Note: The following procedure is only applied to human whole blood red blood cell lysis. Since applications vary, for other samples such as mouse spleen red blood cell lysis (lysing incubation time up to 3 minutes at 37°C), bone marrow red blood cell lysis, each investigator should optimize the condition to obtain optimal results.
1. Add 2.0 ml of 1X lysing solution to each tube containing up to 200 µl of a whole blood plus monoclonal antibody mixture.
2. Gently vortex each tube immediately after adding the lysing solution.
3. Incubate at room temperature, protected from light, for 15 minutes.
4. Centrifuge 200 X g for 5 minutes.
5. Carefully aspirate supernatent, without disturbing pellet.
6. Add 2.0 ml 1X PBS containing 1% heat-inactivated fetal bovine serum and 0.1% sodium azide (PBS-FBS).
7. Centrifuge at 200 X g for 5 minutes.
8. Carefully aspirate supernatent, without disturbing pellet.
9. Resuspend pellet in 0.5 ml PBS-FBS or a fixative such as 2% formaldehyde for flow cytometric analysis.
Troubleshooting: Incomplete lysis may occur for several reasons: (1) The age of the specimen may affect red cell lysis, (2) The 1X lysing solution may not have been warmed to room temperature, or (3) After adding the lysing solution, the samples may not have been vortexed sufficiently. If incomplete lysis occurs (recognized by the presence of an excessive amount of visible red blood cells in the final, washed cell suspension), repeat lysing procedure. However, lysing more than two times is not recommended.
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
Development References (1)
-
Muirhead KA, Wallace PK, Schmitt TC, Frescatore RL, Franco JA, Horan PK. Methodological considerations for implementation of lymphocyte subset analysis in a clinical reference laboratory. Ann N Y Acad Sci. 1986; 468:113-127. (Methodology: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.